San Diego, CA, United States of America

Wendy Loza Hobbs

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Eli Lilly and Company. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wendy Loza Hobbs. Retrieved from https://idiyas.com/inventor/wendy-loza-hobbs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Wendy Loza Hobbs: Innovator in Antibody Research

Introduction

Wendy Loza Hobbs is a prominent inventor based in San Diego, CA. She has made significant contributions to the field of biomedical research, particularly in the development of therapeutic antibodies. Her work focuses on addressing inflammatory diseases and cancer through innovative solutions.

Latest Patents

Wendy holds a patent titled "Anti-Human-IL-1-Beta Antibodies, Encoding Nucleic Acids Thereof and Methods of Using Thereof to Treat Inflammatory Diseases and Cancer." This patent represents her commitment to advancing medical treatments and improving patient outcomes.

Career Highlights

Wendy is currently employed at Eli Lilly and Company, where she continues to push the boundaries of scientific research. Her role at the company allows her to collaborate with other experts in the field and contribute to groundbreaking projects.

Collaborations

One of her notable collaborators is Andrew Dixon Skora, with whom she has worked closely on various research initiatives. Their partnership exemplifies the importance of teamwork in achieving scientific advancements.

Conclusion

Wendy Loza Hobbs is a dedicated inventor whose work in antibody research is making a significant impact in the medical field. Her innovative spirit and commitment to improving healthcare continue to inspire others in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…